Chong Ad Rian, Ng Khai Lip, Huan Nai-Chien, Mohd Aminudin Nur Husna, Raja Rahaizat Raja Nor Adilla, Mohamed Nordin Kasuma
Division of Respiratory Medicine, Department of Internal Medicine Melaka Hospital Melaka Malaysia.
Department of Respiratory Medicine Queen Elizabeth Hospital Kota Kinabalu Sabah Malaysia.
Respirol Case Rep. 2025 Aug 27;13(8):e70334. doi: 10.1002/rcr2.70334. eCollection 2025 Aug.
Pulmonary aspergilloma can cause life-threatening haemoptysis. Surgical resection and/or bronchial artery embolization (BAE) are established treatment modalities, but both can be risky in frail patients with comorbidities. Spontaneous regression of aspergilloma with antifungal agents alone is rare. We report an elderly gentleman with a background history of treated pulmonary tuberculosis, who presented with haemoptysis due to a large left upper lobe aspergilloma. He declined surgery and BAE due to perceived risks. Oral voriconazole and later isavuconazole were prescribed, which led to clinical improvement and significant reduction in the size of the aspergilloma over 6 months. Antifungal agents might be a viable therapeutic option for aspergilloma patients unsuitable or who declined more invasive procedures. Further studies are needed to validate the efficacy and safety of this approach.
肺曲菌球可导致危及生命的咯血。手术切除和/或支气管动脉栓塞术(BAE)是既定的治疗方式,但对于合并症的体弱患者而言,这两种方法都有风险。仅使用抗真菌药物使曲菌球自然消退的情况很罕见。我们报告一位有肺结核治疗史的老年男性,因左上叶巨大曲菌球出现咯血。由于意识到风险,他拒绝了手术和BAE。给予口服伏立康唑,随后换用艾沙康唑,6个月内实现了临床改善且曲菌球大小显著缩小。对于不适合或拒绝更具侵入性手术的曲菌球患者,抗真菌药物可能是一种可行的治疗选择。需要进一步研究来验证这种方法的有效性和安全性。